Mechanisms of HSV-1 helicase-primase inhibition and replication fork complex assembly
Cell · 2026-01 · 189 (2) · 478-494.e18
DOI: 10.1016/j.cell.2025.11.041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026-01. Verfasst von Zishuo Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: DNA Primase, Herpesvirus 1, Human, DNA Helicases, DNA Replication. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIH National Cancer Institute.
Abstract (Originalsprache)
Herpesviruses are widespread double-stranded DNA viruses that establish lifelong latency and cause various diseases. Although DNA-polymerase-targeting antivirals are effective, increasing drug resistance underscores the need for alternatives. Helicase-primase inhibitors (HPIs) are promising antivirals, but their mechanisms of action are poorly defined. Furthermore, how the helicase-primase (H/P) complex and DNA polymerase coordinate genome replication is not well understood for herpesviruses. Here, we report cryo-electron microscopy (cryo-EM) structures of the herpes simplex virus 1 H/P complex bound to HPIs, showing that these lock the H/P complex in an inactive state. Single-molecule assays reveal that HPIs cause H/P complexes to pause in unwinding activity on DNA. The structure of an HPI-bound replication fork complex, comprising the H/P complex (UL5, UL52, and UL8) and the polymerase holoenzyme (UL30 and UL42), reveals a previously uncharacterized interface bridging these complexes. These findings provide a structural framework for understanding herpesvirus replisome assembly and advancing inhibitor development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
- Center for the Development of Therapeutics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
- Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Department of Molecular Biology and Biophysics, University of Connecticut School of Medicine, Farmington, CT, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. Electronic address: joseph_loparo@hms.harvard.edu.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIH National Cancer Institute
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
- National Institutes of Health
- Servier
- Burroughs Wellcome Fund
- Howard Hughes Medical Institute
Zitieren
APA
Yu, Z., Sathyanarayana, P., Liu, C., Tan, J. M. J., Yang, P., Das, B., Hu, S., Fan, X., Ji, C., Weller, S. K., Shekhar, M., Coen, D. M., Kranzusch, P. J., Loparo, J. J., & Abraham, J. (2026). Mechanisms of HSV-1 helicase-primase inhibition and replication fork complex assembly. Cell, 189(2), 478-494.e18. https://doi.org/10.1016/j.cell.2025.11.041
Vancouver
Yu Z, Sathyanarayana P, Liu C, Tan JMJ, Yang P, Das B, et al. Mechanisms of HSV-1 helicase-primase inhibition and replication fork complex assembly. Cell. 2026;189(2):478-494.e18. doi:10.1016/j.cell.2025.11.041
BibTeX
@article{Yu2026,
author = {Yu, Zishuo and Sathyanarayana, Pradeep and Liu, Cong and Tan, Joel M J and Yang, Pan and Das, Biswajit and Hu, Side and Fan, Xiaoyi and Ji, Chenggong and Weller, Sandra K and Shekhar, Mrinal and Coen, Donald M and Kranzusch, Philip J and Loparo, Joseph J and Abraham, Jonathan},
title = {Mechanisms of HSV-1 helicase-primase inhibition and replication fork complex assembly},
journal = {Cell},
year = {2026},
volume = {189},
number = {2},
pages = {478--494.e18},
doi = {10.1016/j.cell.2025.11.041}
}
EUVIMED